Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located

Radiotherapy and Oncology

Volumn 82, Issue 2, 2007, Pages 153-159

  Zhao, Lujun ^a   Chen, Ming ^a   Ten Haken, Randall ^a   Chetty, Indrin ^a   Chapet, Olivier ^a   Hayman, James A ^a   Kong, Feng Ming ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

3D conformal radiation therapy; Dismetric analysis; Incidental nodal irradiation; Node negative disease; NSCLC

Indexed keywords

ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DOSE CALCULATION; DOSIMETRY; ELECTIVE NODAL IRRADIATION; FEMALE; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; IRRADIATION; LUNG NON SMALL CELL CANCER; LYMPH NODE IRRADIATION; MALE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL SIGNIFICANCE; THREE DIMENSIONAL CONFORMAL RADIATION THERAPY; THREE DIMENSIONAL IMAGING;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODES; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; TUMOR BURDEN;

EID: 33847044802     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.01.006     Document Type: Article

References (28)

1. Krol A.D., Aussems P., Noordijk E.M., Hermans J., and Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 (1996) 297-302
2. Cheung P.C., Mackillop W.J., Dixon P., Brundage M.D., Youssef Y.M., and Zhou S. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 703-710
3. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26 (1999) 137-142
4. Lagerwaard F.J., Senan S., van Meerbeeck J.P., and Graveland W.J. Rotterdam oncological thoracic study group. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for stage I non-small cell lung cancer?. Radiother Oncol 63 (2002) 151-157
5. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
6. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?. Radiother Oncol 71 (2004) 123-125
7. Chang D.T., Zlotecki R.A., and Olivier K.R. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am J Clin Oncol 28 (2005) 597-602
8. Ginsberg R.J., and Rubinstein L.V. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg 60 (1995) 615-622
9. Doddoli C., Aragon A., Barlesi F., et al. Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer?. Eur J Cardiothorac Surg 27 (2005) 680-685
10. Lardinois D., Suter H., Hakki H., Rousson V., Betticher D., and Ris H.B. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 80 (2005) 268-274
11. Koike T., Terashima M., Takizawa T., Watanabe T., Kurita Y., and Yokoyama A. Clinical analysis of small-sized peripheral lung cancer. J Thorac Cardiovasc Surg 115 (1998) 1015-1020
12. Ishida T., Yano T., Maeda K., Kaneko S., Tateishi M., and Sugimachi K. Strategy for lymphadenectomy in lung cancer three centimeters or less in diameter. Ann Thorac Surg 50 (1990) 708-713
13. Suzuki K., Nagai K., Yoshida J., Nishimura M., Takahashi K., and Nishiwaki Y. Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer. J Thorac Cardiovasc Surg 117 (1999) 593-598
14. Sawyer T.E., Bonner J.A., Gould P.M., et al. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: implications in the inoperable and three-dimensional dose-escalation settings. Int J Radiat Oncol Biol Phys 43 (1999) 965-970
15. Chen M., Hayman J.A., Ten Haken R.K., Tatro D., Fernando S., and Kong F.M. Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: Is low incidence of regional failure due to incidental nodal irradiation?. Int J Radiat Oncol Biol Phys 64 (2006) 120-126
16. Chapet O., Kong F.M., Quint L.E., et al. CT-based definition of thoracic lymph node stations: an atlas from the University of Michigan. Int J Radiat Oncol Biol Phys 63 (2005) 170-178
17. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
18. Wu Q., Mohan R., Niemierko A., and Schmidt-Ullrich R. Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose. Int J Radiat Oncol Biol Phys 52 (2002) 224-235
19. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., and Leibel S.A. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
20. Bradley J.D., Wahab S., Lockett M.A., Perez C.A., and Purdy J.A. Elective nodal failures are uncommon in medically inoperable patients with stage I non-small-cell lung carcinoma treated with limited radiotherapy fields. Int J Radiat Oncol Biol Phys 56 (2003) 342-347
21. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 (2005) 318-328
22. Martel M.K., Sahijdak W.M., Hayman J.A., and Ball D. Incidental dose to clinically negative nodes from conformal treatment fields for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 45 (1999) 244
23. Takizawa T., Terashima M., Koike T., Akamatsu H., Kurita Y., and Yokoyama A. Mediastinal lymph node metastasis in patients with clinical stage I peripheral non-small-cell lung cancer. J Thorac Cardiovasc Surg 113 (1997) 248-252
24. Kotoulas C.S., Foroulis C.N., Kostikas K., et al. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location. Lung Cancer 44 (2004) 183-191
25. Suwinski R., Maciejewski B., and Withers H.R. Dose-response relationship for elective neck irradiation of head and neck cancer-facts and controversies. Neoplasm 45 (1998) 107-112
26. Withers H.R., and Suwinski R. Radiation dose response for subclinical metastases. Semin Radiat Oncol 8 (1998) 224-228
27. Withers H.R., Peters L.J., and Taylor J.M. Dose-response relationship for radiation therapy of subclinical disease. Int J Radiat Oncol Biol Phys 31 (1995) 353-359
28. Withers H.R., Peters L.J., and Taylor J.M. Dose-response for subclinical disease - in response to Dr. Ben Josef. Int J Radiat Oncol Biol Phys 32 (1995) 1267-1268